Assignee
SHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD
CN·0 granted patents·6 pending applications·0 citations·filing 2021–2022
Top patents by PatentIndex Score
6 records- 0158US2024261418A1Sos1 degrading agent and preparation method therefor and application thereofSHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0258US2024261417A1Sos1 degrading agent and preparation method therefor and application thereofSHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0355US2024368194A1Irak4 degradation agent, and preparation method therefor and use thereofSHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD·Filed 2022·Application pending·0 cites
- 0452US2023210833A1Use of irak4 inhibitor in treatment of acute lung injury ali/ardsSHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0550US2023234936A1Compound for targeting and degrading protein, and preparation method therefor and use thereofSHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0648US2023192655A1Indazole derivative, and preparation method therefor and use thereofSHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI LEADINGTAC PHARMACEUTICAL CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →